Second, because mot‐2 shows overexpression in a wide variety of human cancer cells, VTD‐dependent downregulation of mot‐2 at the protein level through CHIP‐medicated ubiquitination may have a unique translational value. The gene discussed is HSPA9; the disease is cancer.